Sort
21,453 grants matching “tuberculosis”
Options for Delivery of Short-Course Tuberculosis Preventive Therapy: The 3HP Options Trial
$607,486Adithya Cattamanchi · University Of California, San Francisco · R01 · FY2020 · HL
M. tuberculosis metabolites to activate human mucosal-associated invariant T cells
$607,459Shouxiong Huang · Texas Biomedical Research Institute · R01 · FY2025 · AI
Elucidating the path to type I IFNs in TB infection
$607,300Amy K Barczak · Massachusetts General Hospital · R01 · FY2022 · AI
A multi-disciplinary approach to the identification of host metabolic determinan
$607,222Megan Murray · Brigham And Women'S Hospital · U19 · FY2018 · AI
Drug targets in Mtb Gluconeogenesis
$607,211Sabine Ehrt · Weill Medical Coll Of Cornell Univ · R01 · FY2014 · AI
Drug targets in Mtb Gluconeogenesis
$607,211Sabine Ehrt · Weill Medical Coll Of Cornell Univ · R01 · FY2015 · AI
Drug targets in Mtb Gluconeogenesis
$607,211Sabine Ehrt · Weill Medical Coll Of Cornell Univ · R01 · FY2012 · AI
Dissecting functions of IL-23-dependent inflammatory Th17 cells
$607,162Zhiheng He · University Of Southern California · R01 · FY2024 · AI
A RCT of HIV Adherence Case Management and Modified DOT
$607,145Margot B Kushel · University Of California, San Francisco · R01 · FY2007 · MH
Molecular basis of heme scavenging by Gram-positive bacteria
$606,938Robert Thompson Clubb · University Of California Los Angeles · R01 · FY2024 · AI
Molecular basis of heme scavenging by Gram-positive bacteria
$606,938Robert Thompson Clubb · University Of California Los Angeles · R01 · FY2023 · AI
Molecular basis of heme scavenging by Gram-positive bacteria
$606,938Robert Thompson Clubb · University Of California Los Angeles · R01 · FY2021 · AI
Validation and Application of a Model for Human-like TB Latency in Rabbits
$606,449Veronique Dartois · Boston Medical Center · U19 · FY2015 · AI
Establishment of the New York University Vaccine and Treatment Evaluation Unit (NYU VTEU)
$606,446Angelica Cifuentes Kottkamp · New York University School Of Medicine · UM1 · FY2025 · AI
Drug tourism to Mexico: Impact of Mexicos new drug law on HIV-HCV-TB in US IDUs
$606,420Richard S Garfein · University Of California, San Diego · R01 · FY2012 · DA
Transcriptome and proteome remodeling by Mycobacterium tuberculosis MazF toxins
$606,310Nancy Ann Woychik · Rbhs-Robert Wood Johnson Medical School · R01 · FY2021 · AI
Evaluating HBVZ10-Based Therapies for cccDNA Clearance: Virological Foundation and Synergistic Combinations
$606,178Yong-Yuan Zhang · Hbvtech · N43 · FY2025 · AI
Vaccine and Treatment Evaluation Unit at Saint Louis University
$606,000Daniel F. Hoft · Saint Louis University · UM1 · FY2020 · AI
Cell Migration in Tuberculosis Infection
$605,986John R. Chan · Albert Einstein College Of Medicine · R01 · FY2006 · HL
This is a grant to support tuberculosis (TB) control in the state of Connecticut including case management and surveillance activities, educational efforts, and laboratory services for TB control.
$605,967Lynn E Sosa · Connecticut State Dept Of Public Health · U52 · FY2015 · PS
Impact of a New Molecular TB Test on TB/HIV Outcomes among HIV-Infected Malawians
$605,961Richard E Chaisson · Johns Hopkins University · R01 · FY2011 · AI
US BRAZIL COLLABORATION ON IMMUNITY AND BIOMARKERS IN TUBERCULOSIS
$605,629Jerrold J. Ellner · Boston Medical Center · U01 · FY2014 · AI
US BRAZIL COLLABORATION ON IMMUNITY AND BIOMARKERS IN TUBERCULOSIS
$605,604Jerrold J. Ellner · Boston Medical Center · U01 · FY2015 · AI
Regulation of CD8+ T cell immunity to tuberculosis (pending title)
$605,572Samuel M Behar · Univ Of Massachusetts Med Sch Worcester · R01 · FY2013 · AI
Antimicrobial evaluation and development
$605,549Kim Lewis · Northeastern University · P01 · FY2018 · AI